The American journal of gastroenterology · 2026
Identifying Key Predictors of Metastatic Cutaneous Crohn's Disease: A Case-Control Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Baker Natalie M, Santiago-Soltero Karla, Anshelevich Ellen, Ebriani Joseph, Li Kelly, Stein David, Barbieri John S, Dalal Rahul S, Charrow Alexandra P
Аннотация
INTRODUCTION: Metastatic cutaneous Crohn's disease (MCD) is a rare cutaneous manifestation of Crohn's disease (CD) with significant morbidity, yet understanding is limited to case reports and small series. We aimed to identify risk factors associated with MCD development.
METHODS: This retrospective case-control study (January 2016-January 2024) included patients with MCD confirmed using Delphi Panel criteria and controls with gastrointestinal CD, matched 1:2 by age and sex. Demographic factors, CD characteristics, medication history, surgical history, and extraintestinal manifestations were assessed by chart review. Odds ratios were calculated using conditional logistic regression.
RESULTS: Among 474 patients screened, 61 cases were matched with 122 controls. 77.0% were women with no significant differences in smoking history or body mass index between groups. Factors significantly associated with increased MCD odds included perianal CD (OR 6.79, 95% CI 1.47-31.36, P = 0.014) and ostomy history (OR 72.65, 95% CI 3.50-1,505.92, P = 0.006).
DISCUSSION: These findings represent an important step toward understanding MCD's pathogenesis and may inform future translational studies.
METHODS: This retrospective case-control study (January 2016-January 2024) included patients with MCD confirmed using Delphi Panel criteria and controls with gastrointestinal CD, matched 1:2 by age and sex. Demographic factors, CD characteristics, medication history, surgical history, and extraintestinal manifestations were assessed by chart review. Odds ratios were calculated using conditional logistic regression.
RESULTS: Among 474 patients screened, 61 cases were matched with 122 controls. 77.0% were women with no significant differences in smoking history or body mass index between groups. Factors significantly associated with increased MCD odds included perianal CD (OR 6.79, 95% CI 1.47-31.36, P = 0.014) and ostomy history (OR 72.65, 95% CI 3.50-1,505.92, P = 0.006).
DISCUSSION: These findings represent an important step toward understanding MCD's pathogenesis and may inform future translational studies.